CIK 0000784199
- Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 592417093
- Phone
- +1 770-419-3355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | Maney Rochelle L. VP, Quality | Sale | −1,157 | $18.72 | $22K | 46,536 |
| 2024-03-05 | GREEN ANDREW M VP Regulatory | Sale | −1,160 | $18.72 | $22K | 46,541 |
| 2024-03-05 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −1,506 | $18.72 | $28K | 85,438 |
| 2024-03-05 | Horton Amy VP, Chief Accounting Officer | Sale | −1,152 | $18.72 | $22K | 139,957 |
| 2024-03-01 | Horton Amy VP, Chief Accounting Officer | Grant or award | +3,578 | 141,141 | ||
| 2024-03-01 | Stanton Marshall S. SVP, Clinical & MD Affair | Grant or award | +5,724 | 86,985 | ||
| 2024-03-01 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −1,506 | $18.72 | $28K | 85,479 |
| 2024-03-01 | Maney Rochelle L. VP, Quality | Grant or award | +3,578 | 47,726 | ||
| 2024-03-01 | Holloway Jean F SVP, General Counsel | Grant or award | +5,724 | 172,091 | ||
| 2024-03-01 | GREEN ANDREW M VP Regulatory | Grant or award | +3,578 | 47,737 | ||
| 2024-03-01 | Getz Matthew A VP, Human Resources | Grant or award | +3,578 | 49,693 | ||
| 2024-03-01 | Davis John E Chief Commercial Officer | Grant or award | +5,724 | 167,712 | ||
| 2024-03-01 | Mackin James P President & CEO | Grant or award | +28,618 | 720,034 | ||
| 2024-03-01 | Mackin James P President & CEO | Grant or award | +28,618 | 719,558 | ||
| 2024-03-01 | Holloway Jean F SVP, General Counsel | Grant or award | +5,724 | 172,049 | ||
| 2024-03-01 | Davis John E Chief Commercial Officer | Grant or award | +5,724 | 167,659 | ||
| 2024-03-01 | Getz Matthew A VP, Human Resources | Grant or award | +3,578 | 49,660 | ||
| 2024-03-01 | Maney Rochelle L. VP, Quality | Grant or award | +3,578 | 47,693 | ||
| 2024-03-01 | GREEN ANDREW M VP Regulatory | Grant or award | +3,578 | 47,701 | ||
| 2024-03-01 | Stanton Marshall S. SVP, Clinical & MD Affair | Grant or award | +5,724 | 86,944 |
Page 13 of 20 · 388 trades